Jennison Associates LLC Kura Oncology, Inc. Transaction History
Jennison Associates LLC
- $170 Billion
- Q3 2025
A detailed history of Jennison Associates LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 56,731 shares of KURA stock, worth $635,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,731
Previous 142,662
60.23%
Holding current value
$635,387
Previous $823,000
39.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KURA
# of Institutions
213Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...